Mark Massaro
Stock Analyst at BTIG
(4.38)
# 1,282
Out of 5,090 analysts
1053
Total ratings
40.5%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Reiterated: Buy | $33 → $38 | $34.33 | +10.69% | 9 | Oct 27, 2026 | |
| CDNA CareDx | Reiterated: Buy | $74 → $81 | $87.41 | -7.33% | 36 | Oct 27, 2026 | |
| GH Guardant Health | Reiterated: Buy | $195 → $210 | $178.80 | +17.45% | 51 | Oct 27, 2026 | |
| NTRA Natera | Reiterated: Buy | $320 → $430 | $414.30 | +3.79% | 81 | Oct 27, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Hold | n/a | $2.96 | - | 25 | Oct 20, 2026 | |
| MDXH MDxHealth | Downgraded: Hold | n/a | $0.1633 | - | 16 | Oct 19, 2026 | |
| NEO NeoGenomics | Upgraded: Buy | $28 | $17.38 | +61.10% | 36 | Oct 6, 2026 | |
| PSNL Personalis | Downgraded: Hold | n/a | $15.82 | - | 39 | Oct 6, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $25 → $34 | $26.64 | +27.63% | 44 | Sep 22, 2026 | |
| DNA Ginkgo Bioworks Holdings | Reiterated: Sell | $5 | $11.21 | -55.40% | 28 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.59 | - | 30 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $80 | $72.22 | +10.77% | 12 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $12.48 | +36.22% | 1 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.4048 | +517.59% | 25 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.28 | +75.44% | 25 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 | $7.36 | +8.70% | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 → $130 | $113.32 | +14.72% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $7.63 | +17.96% | 19 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $8.59 | +4.77% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $69.06 | +30.32% | 37 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $44 | $37.16 | +18.41% | 35 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $79.72 | +100.70% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $551.21 | +45.14% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.15 | n/a | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $3.70 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0007 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $75 | $13.25 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $8 | $3.94 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $2.91 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $300 → $310 | $235.99 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $173 → $170 | $361.39 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 → $113 | $251.82 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.21 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $12.81 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $149 → $145 | $197.88 | n/a | 2 | May 7, 2015 |
Caris Life Sciences
Oct 27, 2026
Reiterated: Buy
Price Target: $33 → $38
Current: $34.33
Upside: +10.69%
CareDx
Oct 27, 2026
Reiterated: Buy
Price Target: $74 → $81
Current: $87.41
Upside: -7.33%
Guardant Health
Oct 27, 2026
Reiterated: Buy
Price Target: $195 → $210
Current: $178.80
Upside: +17.45%
Natera
Oct 27, 2026
Reiterated: Buy
Price Target: $320 → $430
Current: $414.30
Upside: +3.79%
Insight Molecular Diagnostics
Oct 20, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.96
Upside: -
MDxHealth
Oct 19, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.1633
Upside: -
NeoGenomics
Oct 6, 2026
Upgraded: Buy
Price Target: $28
Current: $17.38
Upside: +61.10%
Personalis
Oct 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $15.82
Upside: -
Adaptive Biotechnologies
Sep 22, 2026
Reiterated: Buy
Price Target: $25 → $34
Current: $26.64
Upside: +27.63%
Ginkgo Bioworks Holdings
Sep 4, 2026
Reiterated: Sell
Price Target: $5
Current: $11.21
Upside: -55.40%
Aug 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.59
Upside: -
Aug 20, 2026
Reiterated: Buy
Price Target: $70 → $80
Current: $72.22
Upside: +10.77%
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $12.48
Upside: +36.22%
Aug 17, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.4048
Upside: +517.59%
Aug 14, 2026
Reiterated: Buy
Price Target: $4
Current: $2.28
Upside: +75.44%
Aug 11, 2026
Upgraded: Buy
Price Target: $8
Current: $7.36
Upside: +8.70%
Aug 6, 2026
Reiterated: Buy
Price Target: $142 → $130
Current: $113.32
Upside: +14.72%
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $7.63
Upside: +17.96%
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $8.59
Upside: +4.77%
Aug 4, 2026
Reiterated: Buy
Price Target: $90
Current: $69.06
Upside: +30.32%
Aug 3, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $37.16
Upside: +18.41%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $79.72
Upside: +100.70%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $551.21
Upside: +45.14%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
May 20, 2024
Reiterated: Buy
Price Target: $2
Current: $3.70
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.0007
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Nov 17, 2019
Reiterated: Buy
Price Target: $70 → $75
Current: $13.25
Upside: n/a
Nov 10, 2019
Reiterated: Hold
Price Target: $7 → $8
Current: $3.94
Upside: n/a
Nov 6, 2019
Reiterated: Buy
Price Target: $35
Current: $2.91
Upside: n/a
Oct 24, 2019
Reiterated: Hold
Price Target: $300 → $310
Current: $235.99
Upside: n/a
Oct 24, 2019
Reiterated: Hold
Price Target: $173 → $170
Current: $361.39
Upside: n/a
Oct 22, 2019
Reiterated: Buy
Price Target: $112 → $113
Current: $251.82
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.21
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $12.81
Upside: n/a
May 7, 2015
Reiterated: Hold
Price Target: $149 → $145
Current: $197.88
Upside: n/a